$0.801
-0.139[-14.79%]
At close: Apr 19
Eloxx Pharmaceuticals
(OTCPK:ELOX)Eloxx Pharmaceuticals Stock (OTC:ELOX), Analyst Ratings, Price Targets, Predictions
Eloxx Pharmaceuticals Inc has a consensus price target of $13.02, established from looking at the 9 latest analyst ratings. The last 3 analyst ratings were released from Oppenheimer, Oppenheimer, and Piper Sandler on July 11, 2023, April 6, 2023, and May 23, 2022. With an average price target of $35.5 between Oppenheimer, Oppenheimer, and Piper Sandler, there's an implied 4331.96% upside for Eloxx Pharmaceuticals Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Oppenheimer
Piper Sandler
HC Wainwright & Co.
Mizuho
B. Riley Securities
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Eloxx Pharmaceuticals
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 07/11/2023 | ELOX | Buy Now | Eloxx Pharmaceuticals | $0.80 | 6766.42% | Oppenheimer | Hartaj Singh | $50 → $55 | Maintains | Outperform | Get Alert |
| 04/06/2023 | ELOX | Buy Now | Eloxx Pharmaceuticals | $0.80 | 6142.2% | Oppenheimer | Hartaj Singh | → $50 | Reiterates | → Outperform | Get Alert |
| 05/23/2022 | ELOX | Buy Now | Eloxx Pharmaceuticals | $0.80 | 87.27% | Piper Sandler | Edward Tenthoff | $160 → $60 | Maintains | Overweight | Get Alert |
| 05/09/2022 | ELOX | Buy Now | Eloxx Pharmaceuticals | $0.80 | -37.58% | HC Wainwright & Co. | Andrew Fein | $40 → $20 | Maintains | Neutral | Get Alert |
| 12/17/2021 | ELOX | Buy Now | Eloxx Pharmaceuticals | $0.80 | 399.38% | Oppenheimer | Hartaj Singh | — | Initiates | → Outperform | Get Alert |
| 11/18/2021 | ELOX | Buy Now | Eloxx Pharmaceuticals | $0.80 | 24.84% | HC Wainwright & Co. | Andrew Fein | — | Maintains | Neutral | Get Alert |
| 11/11/2021 | ELOX | Buy Now | Eloxx Pharmaceuticals | $0.80 | 149.69% | HC Wainwright & Co. | Andrew Fein | — | Maintains | Neutral | Get Alert |
| 06/30/2021 | ELOX | Buy Now | Eloxx Pharmaceuticals | $0.80 | 287.02% | Mizuho | Difei Yang | — | Initiates | → Buy | Get Alert |
| 05/27/2021 | ELOX | Buy Now | Eloxx Pharmaceuticals | $0.80 | 524.22% | B. Riley Securities | Mayank Mamtani | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Eloxx Pharmaceuticals (ELOX)?
The latest price target for Eloxx Pharmaceuticals (OTCPK: ELOX) was reported by Oppenheimer on July 11, 2023. The analyst firm set a price target for $55.00 expecting ELOX to rise to within 12 months (a possible 6766.42% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Eloxx Pharmaceuticals (ELOX)?
The latest analyst rating for Eloxx Pharmaceuticals (OTCPK: ELOX) was provided by Oppenheimer, and Eloxx Pharmaceuticals maintained their outperform rating.
When was the last upgrade for Eloxx Pharmaceuticals (ELOX)?
There is no last upgrade for Eloxx Pharmaceuticals.
When was the last downgrade for Eloxx Pharmaceuticals (ELOX)?
There is no last downgrade for Eloxx Pharmaceuticals.
When is the next analyst rating going to be posted or updated for Eloxx Pharmaceuticals (ELOX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Eloxx Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Eloxx Pharmaceuticals was filed on July 11, 2023 so you should expect the next rating to be made available sometime around July 11, 2024.
Is the Analyst Rating Eloxx Pharmaceuticals (ELOX) correct?
While ratings are subjective and will change, the latest Eloxx Pharmaceuticals (ELOX) rating was a maintained with a price target of $50.00 to $55.00. The current price Eloxx Pharmaceuticals (ELOX) is trading at is $0.80, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.